TOKYO, JAPAN, 10 October 2025– MGI Tech Co., Ltd. (or its affiliates, together referred to as MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Genesis Healthcare Co.(“Genesis Healthcare”), a leading Japan-based genetic testing and research company, have recently the signed a Memorandum of Understanding (MoU) to establish a strategic collaboration. The joint efforts aim to jointly promote precision medicine, multi-omics, and health solutions in Japan.

(MGI Japan Representative Yongheng Cao and Genesis Healthcare Chief Commercial Officer Shuichi Taniguchi signed the MoU)

Under the MoU, the collaboration will integrate MGI’s cutting-edge technological innovation with Genesis Healthcare’s deep expertise and insights in the local Japanese market. By leveraging MGI’s proprietary DNBSEQ™ sequencing technology and ongoing innovation in clinical health applications, the collaboration seeks to strengthen Genesis Healthcare’s capability to deliver comprehensive healthcare solutions. This joint initiative is expected to drive progress in genomic research, prevention and diagnostics, ultimately improve quality of life for the individuals across Japan and Asia.

Dr. Iri Sato Baran, Co-Founder and Vice Chair of the Board of Genesis Healthcare, commented: "We are excited to enter this collaboration with MGI, a leading company in life science tools. This alliance strongly aligns with our strategic vision. It not only allows us to expand our service offerings in Japan but also provides a significant opportunity to explore and develop new business opportunities in China, leveraging our leading position in genomics in Asia with advanced technological platform MGI provides."

Dr. Roy Tan, Director of MGI Northeast Asia, also expressed his enthusiasm: "The innovative spirit and customer-centric approach that Genesis Healthcare embodies are precisely what MGI emphasizes and pursues. We believe that by combining our technologies with Genesis's strong local presence and expertise, together we can greatly enhance the accessibility of advanced genomic technologies for the local community. This partnership is a significant step towards enabling more people to benefit from precision healthcare and the latest biomedical innovations."

About Genesis Healthcare Co. 

Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.

For more information, please visit: https://www.genesis-healthcare.jp/

About MGI

MGI Tech Co., Ltd. (or its affiliates, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries.

Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.

For more information, please visit https://en.mgi-tech.com/, LinkedIn, X, and YouTube.